![](/img/cover-not-exists.png)
A prospective, double-blind, randomized, controlled trial of two second-generation ablation devices, NovaSure GEA and ThermaChoice
MY Bongers, P Bourdrez, B Willem, J Mol, HAM Brölmann, P HeintzVolume:
8
Year:
2001
Language:
english
DOI:
10.1016/s1074-3804(01)80016-5
File:
PDF, 198 KB
english, 2001